Genomic Features Of Exceptional Response In Vemurafenib ± Cobimetinib–treated Patients With BRAFV600-mutated Metastatic Melanoma
Yibing Yan, Matthew J. Wongchenko, Caroline Robert, James Larkin, Paolo A. Ascierto, Brigitte Dréno, Michele Maio, Claus Garbe, Paul B. Chapman, Jeffrey A. Sosman, Zhen Shi, Hartmut Koeppen, Jessie J. Hsu, Ilsung Chang, Ivor Caro, Isabelle Rooney, Grant A. McArthur, Antoni Ribas
Twitter
Facebook
LinkedIn
Email